US12599617B2 Methods of Treating Head and Neck Cancers with Hemp Extract Containing CBD
Summary
The USPTO granted Patent US12599617B2 to Dove Innovation Pty Limited covering methods of treating head and neck cancers using compositions containing hemp-derived CBD. The patent, with 17 claims, specifically covers mucosal formulations of cannabis extract for cancer treatment. Inventors include Alexandra M. Capano, Pradeep Singh Tanwar, and Alex Nance.
What changed
The USPTO issued Patent US12599617B2 to Dove Innovation Pty Limited for a method of treating head and neck cancers using hemp extract containing CBD, administered as a mucosal formulation. The patent contains 17 claims and names Alexandra M. Capano, Pradeep Singh Tanwar, and Alex Nance as inventors.
For pharmaceutical and biotech companies developing CBD-based therapeutics, this patent establishes IP protection in the head and neck cancer treatment space. Companies should review their R&D pipelines for potential overlap with these claims and consider proactive licensing strategies or design-around approaches to avoid infringement exposure.
What to do next
- Review patent claims for potential infringement
- Monitor for related USPTO filings by competitors
- Consult IP counsel regarding licensing opportunities
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods of treating head and neck cancers with hemp extract
Grant US12599617B2 Kind: B2 Apr 14, 2026
Assignee
Dove Innovation Pty Limited
Inventors
Alexandra M. Capano, Pradeep Singh Tanwar, Alex Nance
Abstract
A method for treating a head or neck cancer comprising: administering to a patient an effective amount of a composition comprising a cannabis extract comprising cannabidiol (CBD), wherein the composition is preferably administered as a mucosal formulation.
CPC Classifications
A61P 35/00
Filing Date
2022-10-26
Application No.
18049966
Claims
17
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.